Leo Rasche
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 149
- Multiple Myeloma Research and Treatments 148
- Oncology 92
- CAR-T cell therapy research 39
- Peptidase Inhibition and Analysis 22
- Cancer Treatment and Pharmacology 14
- Co-authors
- Hermann Einsele (64 shared papers)Niels Weinhold (25 shared papers)Klaus Martin Kortüm (41 shared papers)Johannes Duell (16 shared papers)Andreas Rosenwald (13 shared papers)Gareth John Morgan (16 shared papers)Stefan Tobias Knop (14 shared papers)Max S. Topp (8 shared papers)
- Journals
- Blood (32 papers)Haematologica (16 papers)HemaSphere (13 papers)Leukemia (11 papers)Annals of Hematology (7 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Leo Rasche
188 papers receiving 5.4k citations
Leo Rasche's Hit Papers
Peers
Comparison fields: 5 of 96
- Hematology 3.4k
- Oncology 2.7k
- Molecular Biology 2.4k
- Immunology 698
- Genetics 332
Countries citing papers authored by Leo Rasche
This map shows the geographic impact of Leo Rasche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Rasche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Rasche more than expected).
Fields of papers citing papers by Leo Rasche
This network shows the impact of papers produced by Leo Rasche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Rasche. The network helps show where Leo Rasche may publish in the future.
Co-authors
The 25 scholars most cited alongside Leo Rasche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 337 | |
| 2 | Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma Hit paper breakdown → | 2021 | 261 |
| 3 | Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma Hit paper breakdown → | 2023 | 233 |
| 4 | 2017 | 230 | |
| 5 | 2017 | 199 | |
| 6 | 2016 | 182 | |
| 7 | Extramedullary disease in multiple myeloma: a systematic literature review Hit paper breakdown → | 2022 | 165 |
| 8 | 2018 | 128 | |
| 9 | 2021 | 113 | |
| 10 | 2013 | 103 | |
| 11 | 2017 | 100 | |
| 12 | 2018 | 95 | |
| 13 | 2016 | 94 | |
| 14 | 2012 | 79 | |
| 15 | 2021 | 79 | |
| 16 | 2015 | 73 | |
| 17 | 2015 | 70 | |
| 18 | 2019 | 70 | |
| 19 | Real-world analysis of teclistamab in 123 RRMM patients from Germany Hit paper breakdown → | 2024 | 68 |
| 20 | 2017 | 67 |
About Leo Rasche
Leo Rasche is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 207 papers that have together received 5.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (148 papers), Protein Degradation and Inhibitors (55 papers), CAR-T cell therapy research (39 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Peptidase Inhibition and Analysis (22 papers), Cancer Treatment and Pharmacology (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Hematology (3.4k citations), Oncology (2.7k citations), Molecular Biology (2.4k citations), Immunology (698 citations) and Genetics (332 citations). Leo Rasche has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Hermann Einsele, Niels Weinhold, Klaus Martin Kortüm, Johannes Duell, Andreas Rosenwald, Gareth John Morgan, Stefan Tobias Knop, Max S. Topp, Markus Kapp and Sophia Danhof. Their work appears in journals such as Blood, Haematologica, HemaSphere, Leukemia and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.